2026 Geromedicine Conference | Panel 4

Watch Panel 4 from the NUS Academy for Healthy Longevity’s 2026 Geromedicine Conference, exploring the ethical, regulatory, and practical considerations involved in bringing geroprotective interventions from research and development into real-world clinical and community settings. Geroprotective interventions aim to support healthier ageing by targeting biological processes associated with ageing and age-related disease. This panel examines the pathways needed to evaluate, regulate, implement, and responsibly scale these interventions—while considering patient safety, clinical evidence, public policy, accessibility, equity, and the broader implications of extending healthspan. The discussion brings together perspectives from academia, healthcare, public policy, industry, and the longevity sector: Moderator Professor Hans Meij — Co-founder, NUS Academy for Healthy Longevity Panellists Mr Henry Kwek — Member of Parliament Professor Paul Anantharajah Tambyah — Senior Consultant, NUHS Dr Lars Hartenstein — Director, McKinsey Health Institute Mr Marek Piotrowski — Founder, LiveBeyond.world Together, the panellists consider how geroprotective approaches can be translated into responsible and effective practice, and what is required to build trust among patients, healthcare professionals, regulators, policymakers, and the public. The 2026 Geromedicine Conference brings together researchers, clinicians, policymakers, and industry experts to explore advances in geroscience, geromedicine, healthy ageing, and healthspan optimisation. #Geromedicine #GeroprotectiveInterventions #HealthyLongevity #HealthyAgeing #Healthspan #Geroscience #LongevityMedicine #ClinicalResearch #HealthcareInnovation #MedicalEthics #RegulatoryScience #HealthPolicy #NUSMedicine #NUSAcademyForHealthyLongevity